Literature DB >> 22148578

Magnetic silica nanoparticle cellular uptake and cytotoxicity regulated by electrostatic polyelectrolytes-DNA loading at their surface.

Ana B Davila-Ibanez1, Veronica Salgueirino, Vicenta Martinez-Zorzano, Rosalia Mariño-Fernández, Andres García-Lorenzo, Melodie Maceira-Campos, Monica Muñoz-Ubeda, Elena Junquera, Emilio Aicart, Jose Rivas, F Javier Rodriguez-Berrocal, Jose L Legido.   

Abstract

Magnetic silica nanoparticles show great promise for drug delivery. The major advantages correspond to their magnetic nature and ease of biofunctionalization, which favors their ability to interact with cells and tissues. We have prepared magnetic silica nanoparticles with DNA fragments attached on their previously polyelectrolyte-primed surface. The remarkable feature of these materials is the compromise between the positive charges of the polyelectrolytes and the negative charges of the DNA. This dual-agent formulation dramatically changes the overall cytotoxicity and chemical degradation of the nanoparticles, revealing the key role that surface functionalization plays in regulating the mechanisms involved.
© 2011 American Chemical Society

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22148578     DOI: 10.1021/nn204231g

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  9 in total

1.  In vitro toxicity evaluation of silica-coated iron oxide nanoparticles in human SHSY5Y neuronal cells.

Authors:  Gözde Kiliç; Carla Costa; Natalia Fernández-Bertólez; Eduardo Pásaro; João Paulo Teixeira; Blanca Laffon; Vanessa Valdiglesias
Journal:  Toxicol Res (Camb)       Date:  2015-10-23       Impact factor: 3.524

2.  Effects of Mesoporous Silica Coating and Post-Synthetic Treatment on the Transverse Relaxivity of Iron Oxide Nanoparticles.

Authors:  Katie R Hurley; Yu-Shen Lin; Jinjin Zhang; Sam M Egger; Christy L Haynes
Journal:  Chem Mater       Date:  2013-05-14       Impact factor: 9.811

3.  Size-selective separation of DNA fragments by using lysine-functionalized silica particles.

Authors:  Lingling Liu; Zilong Guo; Zhenzhen Huang; Jiaqi Zhuang; Wensheng Yang
Journal:  Sci Rep       Date:  2016-02-25       Impact factor: 4.379

Review 4.  Controlled drug delivery systems for cancer based on mesoporous silica nanoparticles.

Authors:  Nerea Iturrioz-Rodríguez; Miguel A Correa-Duarte; Mónica L Fanarraga
Journal:  Int J Nanomedicine       Date:  2019-05-08

5.  Disruption of Cell Adhesion and Cytoskeletal Networks by Thiol-Functionalized Silica-Coated Iron Oxide Nanoparticles.

Authors:  Karel Královec; Lucie Melounková; Marcela Slováková; Nikola Mannová; Miloš Sedlák; Jan Bartáček; Radim Havelek
Journal:  Int J Mol Sci       Date:  2020-12-08       Impact factor: 5.923

6.  In vivo targeted delivery of nucleic acids and CRISPR genome editors enabled by GSH-responsive silica nanoparticles.

Authors:  Yuyuan Wang; Pawan K Shahi; Xiuxiu Wang; Ruosen Xie; Yi Zhao; Min Wu; Seth Roge; Bikash R Pattnaik; Shaoqin Gong
Journal:  J Control Release       Date:  2021-06-23       Impact factor: 11.467

7.  Toxicity assessment of silica coated iron oxide nanoparticles and biocompatibility improvement by surface engineering.

Authors:  Maria Ada Malvindi; Valeria De Matteis; Antonio Galeone; Virgilio Brunetti; George C Anyfantis; Athanassia Athanassiou; Roberto Cingolani; Pier Paolo Pompa
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

8.  Synthesis of Distinct Iron Oxide Nanomaterial Shapes Using Lyotropic Liquid Crystal Solvents.

Authors:  Seyyed Muhammad Salili; Matthew Worden; Ahlam Nemati; Donald W Miller; Torsten Hegmann
Journal:  Nanomaterials (Basel)       Date:  2017-08-02       Impact factor: 5.076

9.  Silica Coating of Ferromagnetic Iron Oxide Magnetic Nanoparticles Significantly Enhances Their Hyperthermia Performances for Efficiently Inducing Cancer Cells Death In Vitro.

Authors:  Cristian Iacoviță; Ionel Fizeșan; Stefan Nitica; Adrian Florea; Lucian Barbu-Tudoran; Roxana Dudric; Anca Pop; Nicoleta Vedeanu; Ovidiu Crisan; Romulus Tetean; Felicia Loghin; Constantin Mihai Lucaciu
Journal:  Pharmaceutics       Date:  2021-11-27       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.